APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metformin Hydrochloride and Glipizide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metformin Hydrochloride and Glipizide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025183 pages

Choose your research edition.

Industry ResearchMetformin Hydrochloride and Glipizide Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Hydrochloride and Glipizide Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Metformin Hydrochloride and Glipizide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Hydrochloride and Glipizide Tablets Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Hydrochloride and Glipizide Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Metformin Hydrochloride and Glipizide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metformin Hydrochloride and Glipizide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metformin Hydrochloride and Glipizide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metformin Hydrochloride and Glipizide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metformin Hydrochloride and Glipizide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metformin Hydrochloride and Glipizide Tablets include YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical, Xi'an Lijun Pharmaceutical, Hunan Warrant Pharmaceutical, Hefei Lifeon Pharmaceutical, Disha Pharmaceutical Group, Beijing Sihuan Kebao Pharmaceutical, Viatris and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metformin Hydrochloride and Glipizide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metformin Hydrochloride and Glipizide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metformin Hydrochloride and Glipizide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin Hydrochloride and Glipizide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Metformin Hydrochloride and Glipizide Tablets Segment by Company

YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical

Xi'an Lijun Pharmaceutical

Hunan Warrant Pharmaceutical

Hefei Lifeon Pharmaceutical

Disha Pharmaceutical Group

Beijing Sihuan Kebao Pharmaceutical

Viatris

Teva Pharmaceuticals

Metformin Hydrochloride and Glipizide Tablets Segment by Type

Original Drug

Generic Drug

Metformin Hydrochloride and Glipizide Tablets Segment by Application

Hospital and Clinic

Pharmacy

Metformin Hydrochloride and Glipizide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride and Glipizide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride and Glipizide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride and Glipizide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metformin Hydrochloride and Glipizide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metformin Hydrochloride and Glipizide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metformin Hydrochloride and Glipizide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metformin Hydrochloride and Glipizide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metformin Hydrochloride and Glipizide Tablets Industry Trends Table 2. Metformin Hydrochloride and Glipizide Tablets Industry Drivers Table 3. Metformin Hydrochloride and Glipizide Tablets Industry Opportunities and Challenges Table 4. Metformin Hydrochloride and Glipizide Tablets Industry Restraints Table 5. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metformin Hydrochloride and Glipizide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Manufacturers Table 9. Global Metformin Hydrochloride and Glipizide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Metformin Hydrochloride and Glipizide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metformin Hydrochloride and Glipizide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metformin Hydrochloride and Glipizide Tablets Manufacturers, Product Type & Application Table 13. Global Metformin Hydrochloride and Glipizide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metformin Hydrochloride and Glipizide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Metformin Hydrochloride and Glipizide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Metformin Hydrochloride and Glipizide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Metformin Hydrochloride and Glipizide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Global Metformin Hydrochloride and Glipizide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Metformin Hydrochloride and Glipizide Tablets Sales by Application (2021-2026) & (K Units) Table 32. Global Metformin Hydrochloride and Glipizide Tablets Sales by Application (2027-2032) & (K Units) Table 33. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Application (2021-2026) Table 34. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Application (2027-2032) Table 35. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application (2021-2026) & (K Units) Table 37. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application (2027-2032) & (K Units) Table 38. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Metformin Hydrochloride and Glipizide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Metformin Hydrochloride and Glipizide Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Region (2021-2026) Table 43. Global Metformin Hydrochloride and Glipizide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Metformin Hydrochloride and Glipizide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2026) & (K Units) Table 47. North America Metformin Hydrochloride and Glipizide Tablets Sales by Country (2027-2032) & (K Units) Table 48. Europe Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2026) & (K Units) Table 50. Europe Metformin Hydrochloride and Glipizide Tablets Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales by Country (2027-2032) & (K Units) Table 57. Global Metformin Hydrochloride and Glipizide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Region (2027-2032) Table 62. YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Company Information Table 63. YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Business Overview Table 64. YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 66. YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Recent Development Table 67. Xi'an Lijun Pharmaceutical Company Information Table 68. Xi'an Lijun Pharmaceutical Business Overview Table 69. Xi'an Lijun Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Xi'an Lijun Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 71. Xi'an Lijun Pharmaceutical Recent Development Table 72. Hunan Warrant Pharmaceutical Company Information Table 73. Hunan Warrant Pharmaceutical Business Overview Table 74. Hunan Warrant Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hunan Warrant Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 76. Hunan Warrant Pharmaceutical Recent Development Table 77. Hefei Lifeon Pharmaceutical Company Information Table 78. Hefei Lifeon Pharmaceutical Business Overview Table 79. Hefei Lifeon Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hefei Lifeon Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 81. Hefei Lifeon Pharmaceutical Recent Development Table 82. Disha Pharmaceutical Group Company Information Table 83. Disha Pharmaceutical Group Business Overview Table 84. Disha Pharmaceutical Group Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Disha Pharmaceutical Group Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 86. Disha Pharmaceutical Group Recent Development Table 87. Beijing Sihuan Kebao Pharmaceutical Company Information Table 88. Beijing Sihuan Kebao Pharmaceutical Business Overview Table 89. Beijing Sihuan Kebao Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Beijing Sihuan Kebao Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 91. Beijing Sihuan Kebao Pharmaceutical Recent Development Table 92. Viatris Company Information Table 93. Viatris Business Overview Table 94. Viatris Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Viatris Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 96. Viatris Recent Development Table 97. Teva Pharmaceuticals Company Information Table 98. Teva Pharmaceuticals Business Overview Table 99. Teva Pharmaceuticals Metformin Hydrochloride and Glipizide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Teva Pharmaceuticals Metformin Hydrochloride and Glipizide Tablets Product Portfolio Table 101. Teva Pharmaceuticals Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Metformin Hydrochloride and Glipizide Tablets Distributors List Table 105. Metformin Hydrochloride and Glipizide Tablets Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Metformin Hydrochloride and Glipizide Tablets Product Image Figure 2. Global Metformin Hydrochloride and Glipizide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Hydrochloride and Glipizide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Metformin Hydrochloride and Glipizide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Metformin Hydrochloride and Glipizide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metformin Hydrochloride and Glipizide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Metformin Hydrochloride and Glipizide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Global Metformin Hydrochloride and Glipizide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Country (2021-2032) Figure 38. China Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Metformin Hydrochloride and Glipizide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Metformin Hydrochloride and Glipizide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Metformin Hydrochloride and Glipizide Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Metformin Hydrochloride and Glipizide Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical
  • Xi'an Lijun Pharmaceutical
  • Hunan Warrant Pharmaceutical
  • Hefei Lifeon Pharmaceutical
  • Disha Pharmaceutical Group
  • Beijing Sihuan Kebao Pharmaceutical
  • Viatris
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metformin Hydrochloride and Glipizide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metformin Hydrochloride and Glipizide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metformin Hydrochloride and Glipizide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metformin Hydrochloride and Glipizide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metformin Hydrochloride and Glipizide Tablets Market Dynamics
  1. 2.1 Metformin Hydrochloride and Glipizide Tablets Industry Trends
  2. 2.2 Metformin Hydrochloride and Glipizide Tablets Industry Drivers
  3. 2.3 Metformin Hydrochloride and Glipizide Tablets Industry Opportunities and Challenges
  4. 2.4 Metformin Hydrochloride and Glipizide Tablets Industry Restraints
3 Metformin Hydrochloride and Glipizide Tablets Market by Manufacturers
  1. 3.1 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metformin Hydrochloride and Glipizide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metformin Hydrochloride and Glipizide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metformin Hydrochloride and Glipizide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metformin Hydrochloride and Glipizide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Metformin Hydrochloride and Glipizide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metformin Hydrochloride and Glipizide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metformin Hydrochloride and Glipizide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metformin Hydrochloride and Glipizide Tablets Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride and Glipizide Tablets Market by Type
  1. 4.1 Metformin Hydrochloride and Glipizide Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Type
  5. 4.2.1 Global Metformin Hydrochloride and Glipizide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type
  9. 4.3.1 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Type (2021-2032)
5 Metformin Hydrochloride and Glipizide Tablets Market by Application
  1. 5.1 Metformin Hydrochloride and Glipizide Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Application
  5. 5.2.1 Global Metformin Hydrochloride and Glipizide Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Metformin Hydrochloride and Glipizide Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application
  9. 5.3.1 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Application (2021-2032)
6 Global Metformin Hydrochloride and Glipizide Tablets Sales by Region
  1. 6.1 Global Metformin Hydrochloride and Glipizide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metformin Hydrochloride and Glipizide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Metformin Hydrochloride and Glipizide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Metformin Hydrochloride and Glipizide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region
  1. 7.1 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region
  2. 7.1.1 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Metformin Hydrochloride and Glipizide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Metformin Hydrochloride and Glipizide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metformin Hydrochloride and Glipizide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical
  2. 8.1.1 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Company Information
  3. 8.1.2 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Business Overview
  4. 8.1.3 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  6. 8.1.5 YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Recent Developments
  7. 8.2 Xi'an Lijun Pharmaceutical
  8. 8.2.1 Xi'an Lijun Pharmaceutical Company Information
  9. 8.2.2 Xi'an Lijun Pharmaceutical Business Overview
  10. 8.2.3 Xi'an Lijun Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Lijun Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  12. 8.2.5 Xi'an Lijun Pharmaceutical Recent Developments
  13. 8.3 Hunan Warrant Pharmaceutical
  14. 8.3.1 Hunan Warrant Pharmaceutical Company Information
  15. 8.3.2 Hunan Warrant Pharmaceutical Business Overview
  16. 8.3.3 Hunan Warrant Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hunan Warrant Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  18. 8.3.5 Hunan Warrant Pharmaceutical Recent Developments
  19. 8.4 Hefei Lifeon Pharmaceutical
  20. 8.4.1 Hefei Lifeon Pharmaceutical Company Information
  21. 8.4.2 Hefei Lifeon Pharmaceutical Business Overview
  22. 8.4.3 Hefei Lifeon Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hefei Lifeon Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  24. 8.4.5 Hefei Lifeon Pharmaceutical Recent Developments
  25. 8.5 Disha Pharmaceutical Group
  26. 8.5.1 Disha Pharmaceutical Group Company Information
  27. 8.5.2 Disha Pharmaceutical Group Business Overview
  28. 8.5.3 Disha Pharmaceutical Group Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Disha Pharmaceutical Group Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  30. 8.5.5 Disha Pharmaceutical Group Recent Developments
  31. 8.6 Beijing Sihuan Kebao Pharmaceutical
  32. 8.6.1 Beijing Sihuan Kebao Pharmaceutical Company Information
  33. 8.6.2 Beijing Sihuan Kebao Pharmaceutical Business Overview
  34. 8.6.3 Beijing Sihuan Kebao Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Sihuan Kebao Pharmaceutical Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  36. 8.6.5 Beijing Sihuan Kebao Pharmaceutical Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Metformin Hydrochloride and Glipizide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Metformin Hydrochloride and Glipizide Tablets Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metformin Hydrochloride and Glipizide Tablets Value Chain Analysis
  2. 9.1.1 Metformin Hydrochloride and Glipizide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metformin Hydrochloride and Glipizide Tablets Production Mode & Process
  6. 9.2 Metformin Hydrochloride and Glipizide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metformin Hydrochloride and Glipizide Tablets Distributors
  9. 9.2.3 Metformin Hydrochloride and Glipizide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst